Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
Robert N, Leyland-Jones B, Asmar L, Belt R, Ilegbodu D, Loesch D, Raju R, Valentine E, Sayre R, Cobleigh M, Albain K, McCullough C, Fuchs L, Slamon D. Robert N, et al. Among authors: ilegbodu d. J Clin Oncol. 2006 Jun 20;24(18):2786-92. doi: 10.1200/JCO.2005.04.1764. J Clin Oncol. 2006. PMID: 16782917 Clinical Trial.
Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer.
Kolodziej M, Neubauer MA, Rousey SR, Pluenneke RE, Perrine G, Mull S, Boehm KA, Ilegbodu D, Asmar L. Kolodziej M, et al. Among authors: ilegbodu d. Clin Genitourin Cancer. 2006 Sep;5(2):155-61. doi: 10.3816/CGC.2006.n.033. Clin Genitourin Cancer. 2006. PMID: 17026805 Clinical Trial.
Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma.
Carter DL, Asmar L, Barrera D, Caracandas J, Dakhil JS, McCracken D, O'Rourke MA, Rosenberg RK, Boehm KA, Ilegbodu D, Reid RL. Carter DL, et al. Among authors: ilegbodu d. Invest New Drugs. 2008 Oct;26(5):473-81. doi: 10.1007/s10637-008-9128-1. Epub 2008 May 13. Invest New Drugs. 2008. PMID: 18473121 Clinical Trial.
A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancer.
Carter DL, Garfield D, Hathorn J, Mundis R, Boehm KA, Ilegbodu D, Asmar L, Reynolds C. Carter DL, et al. Among authors: ilegbodu d. Clin Lung Cancer. 2012 May;13(3):205-13. doi: 10.1016/j.cllc.2011.10.005. Epub 2011 Dec 3. Clin Lung Cancer. 2012. PMID: 22138037 Clinical Trial.
16 results